Statistics about Health, Pharma & Medtech in United States
Statistics
- Effector Therapeutics, Inc. operating profit 2020-2023
- Effector Therapeutics, Inc. revenue 2020-2023
- Bluebird Bio net income 2016-2019
- Wellness Center Usa total equity 2017-2021
- Wellness Center Usa net cash 2017-2021
- Wellness Center Usa liabilities 2014-2021
- Wellness Center Usa operating profit 2017-2021
- Wellness Center Usa gross profit 2017-2021
- Wellness Center Usa revenue 2017-2021
- Applied Genetic Technologies Corp total equity 2018-2022
- Vyant Bio, Inc. total equity 2018-2022
- Applied Genetic Technologies Corp net cash 2018-2022
- Albireo Pharma, Inc. operating profit 2017-2021
- 180 Life Sciences Corp. net income 2020-2022
- Actavia Life Sciences, Inc. total equity 2019-2023
- Agile Therapeutics operating profit 2019-2023
- Actavia Life Sciences, Inc. net cash 2019-2023
- Actavia Life Sciences, Inc. operating profit 2019-2023
- Aerie Pharmaceuticals Inc operating profit 2017-2021
- Actavia Life Sciences, Inc. net income 2015-2021
- Applied Genetic Technologies Corp operating profit 2018-2022
- Agile Therapeutics gross profit 2020-2023
- 9 Meters Biopharma total equity 2018-2022
- 9 Meters Biopharma net cash 2018-2022
- Albireo Pharma, Inc. revenue 2017-2021
- 9 Meters Biopharma gross profit 2015-2017
- 9 Meters Biopharma operating profit 2018-2022
- Applied Genetic Technologies Corp revenue 2018-2022
- Agile Therapeutics revenue 2019-2023
- Vyant Bio, Inc. net cash 2018-2022
- Aerie Pharmaceuticals Inc revenue 2017-2021
- Applied Genetic Technologies Corp net income 2016-2020
- Albireo Pharma, Inc. net income 2017-2021
- Albireo Pharma, Inc. total equity 2017-2021
- Aim Immunotech Inc. net income 2010-2014
- Agile Therapeutics net income 2019-2023
- Aerie Pharmaceuticals Inc total equity 2017-2021
- Vyant Bio, Inc. liabilities 2018-2022
- Albireo Pharma, Inc. net cash 2017-2021
- Agile Therapeutics net cash 2019-2023
- Vyant Bio, Inc. operating profit 2018-2022
- Aerie Pharmaceuticals Inc net cash 2017-2021
- Viracta Therapeutics, Inc. total equity 2019-2023
- Viracta Therapeutics, Inc. net cash 2019-2023
- Viracta Therapeutics, Inc. liabilities 2018-2023
- Viracta Therapeutics, Inc. revenue 2016-2020
- Vistagen Therapeutics, Inc. net income 2011-2014
- Viracta Therapeutics, Inc. net income 2017-2020
- Vaxxinity total equity 2019-2023
- Vaxxinity net cash 2020-2023
- Vaxxinity liabilities 2020-2023
- Vaxxinity operating profit 2020-2023
- Vaxxinity revenue 2020-2022
- Vaccinex total equity 2017-2021
- Unicycive Therapeutics revenue 2022-2023
- Ultragenyx Pharmaceutical net income 2016-2020
- Benitec Biopharma Inc. revenue 2020-2024
- Titan Pharmaceuticals revenue 2019-2023
- Theralink Technologies total equity 2019-2023
- Tff Pharmaceuticals total equity 2019-2023
- Theralink Technologies net cash 2019-2023
- Tff Pharmaceuticals net cash 2019-2023
- Theralink Technologies operating profit 2019-2023
- Tff Pharmaceuticals operating profit 2019-2023
- Theralink Technologies gross profit 2012-2023
- Tenax Therapeutics gross profit 2011-2016
- Theralink Technologies revenue 2014-2023
- Tff Pharmaceuticals revenue 2021-2023
- Tcr2 Therapeutics Inc. total equity 2018-2022
- Tauriga Sciences total equity 2016-2020
- Syros Pharmaceuticals total equity 2019-2023
- Retrieve Medical Holdings total equity 2018-2022
- Tcr2 Therapeutics Inc. net cash 2018-2022
- Tauriga Sciences net cash 2016-2020
- Syros Pharmaceuticals net cash 2019-2023
- Retrieve Medical Holdings net cash 2018-2022
- Tcr2 Therapeutics Inc. operating profit 2018-2022
- Tauriga Sciences operating profit 2016-2020
- Syros Pharmaceuticals operating profit 2019-2023
- Retrieve Medical Holdings operating profit 2018-2022
- Tauriga Sciences gross profit 2014-2020
- Tauriga Sciences revenue 2017-2020
- Syros Pharmaceuticals revenue 2019-2023
- Retrieve Medical Holdings revenue 2018-2022
- Tauriga Sciences net income 2012-2019
- Tg Therapeutics net income 2018-2022
- Tff Pharmaceuticals net income 2018-2022
- Syros Pharmaceuticals net income 2019-2023
- Retrieve Medical Holdings net income 2018-2022
- Tnf Pharmaceuticals, Inc. revenue 2015-2019
- Tnf Pharmaceuticals, Inc. gross profit 2015-2019
- Stem Holdings, Inc. total equity 2019-2023
- Statera Biopharma, Inc. total equity 2017-2021
- Sorrento Therapeutics total equity 2018-2022
- Stem Holdings, Inc. net cash 2019-2023
- Statera Biopharma, Inc. net cash 2013-2021
- Sorrento Therapeutics net cash 2018-2022
- Stem Holdings, Inc. operating profit 2019-2023
- Statera Biopharma, Inc. operating profit 2017-2021
- Sorrento Therapeutics operating profit 2018-2022